2'-O-Methyl-N1-methyl inosine manufacturers
|
| | 2'-O-Methyl-N1-methyl inosine Basic information |
| Product Name: | 2'-O-Methyl-N1-methyl inosine | | Synonyms: | 2'-O-Methyl-N1-methyl inosine;Inosine, 1-methyl-2'-O-methyl-;1,2'-O-dimethylinosine;2’-O-Methyl-N1-methylinosine;1,O2'-dimethylinosine;1-Methyl-2'-O-methylinosine;9-(4-hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)-1-methyl-1,2,3,9-tetrahydro-6H-purin-6-one | | CAS: | 65150-69-8 | | MF: | C12H16N4O5 | | MW: | 296.28 | | EINECS: | | | Product Categories: | | | Mol File: | 65150-69-8.mol |  |
| | 2'-O-Methyl-N1-methyl inosine Chemical Properties |
| Boiling point | 644.8±65.0 °C(Predicted) | | density | 1.69±0.1 g/cm3(Predicted) | | pka | 13.20±0.70(Predicted) |
| | 2'-O-Methyl-N1-methyl inosine Usage And Synthesis |
| Uses | 1-Methyl-2'-O-methylinosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | 2'-O-Methyl-N1-methyl inosine Preparation Products And Raw materials |
|